Last edition
News about
NPPA fixes retail prices of 11 formulations under DPCO-2013
The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 11 formulations under Drugs Prices Control Order (DPCO) - 2013 based on the decision of 89th authority meeting dated June 28, 2021
Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), and Alyatec, a contract research organisation based in Strasbourg University Hospital (France), announced that they have entered into a collaboration to advance precision medicine in AIT
Roche announced that the cobas MTB and cobas MTB-RIF/INH tests for use on the cobas 6800/8800 Systems are included as part of the updated World Health Organization (WHO) policy guidelines on nucleic acid amplification tests (NAATs) to detect tuberculosis (TB) and drug-resistant TB
Managed by the Broad Institute of MIT and Harvard, the browser gives access to results from analyses of whole exome sequencing data from 300,000 UK Biobank research participants. These genetic data have been paired with detailed health information to create this browsable resource
Alembic Pharma receives US FDA approval for generic Tarceva tablets
Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for erlotinib tablets, 25 mg, 100 mg, and 150 mg
The Central Drugs Standard Control Organisation (CDSCO) has directed active pharmaceutical ingredient (API) manufacturers to file online applications for issuance of written confirmation certificate (WCC) on the new SUGAM module. For exporting APIs to European Union (EU) countries, a written confirmation certificate is must
IGBA launches a whitepaper: A vision for the generic and biosimilar medicines industry
The International Generic and Biosimilar Medicines Association (IGBA) has announced the launch of a whitepaper: A vision for the generic and biosimilar medicines industry, which covers the strong contribution of this pharmaceutical sector to global health outcomes and economies, the opportunities, challenges and disruptions for the industry
Seegene announced on June 1 the signing of an agreement with Bio-Rad Laboratories, Inc. to develop and commercialize products for molecular diagnostics of infectious diseases. Under the terms of the agreement, Seegene will provide diagnostic tests for use in Bio-Rad's CFX96 Dx Real-Time PCR System for the United States market
Pfeiffer Vacuum's virtual showroom: Leak testing and CCIT solutions for the pharmaceutical industry
Visitors to the site will find information about the challenges of leak testing IV bags, syringes, blister packs, plastic bottles, vials and other non-porous containers. At the virtual trade show booth, visitors will learn about Pfeiffer Vacuum's unique portfolio of leak detectors
Sosei Group Corporation and InveniAI, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across drug discovery and development, announced the initiation of a new R&D collaboration
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy